Cavan M. Redmond - Net Worth and Insider Trading
Cavan M. Redmond Net Worth
The estimated net worth of Cavan M. Redmond is at least $16,463 dollars as of 2024-09-20. Cavan M. Redmond is the Director of OncoCyte Corp and owns about 5,543 shares of OncoCyte Corp (OCX) stock worth over $16,463. Details can be seen in Cavan M. Redmond's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cavan M. Redmond has not made any transactions after 2022-03-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Cavan M. Redmond
Cavan M. Redmond Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cavan M. Redmond owns 3 companies in total, including OncoCyte Corp (OCX) , Lineage Cell Therapeutics Inc (LCTX) , and Pfizer Inc (PFE) .
Click here to see the complete history of Cavan M. Redmond’s form 4 insider trades.
Insider Ownership Summary of Cavan M. Redmond
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OCX | OncoCyte Corp | 2022-03-16 | director |
| LCTX | Lineage Cell Therapeutics Inc | 2018-02-21 | director |
| PFE | Pfizer Inc | 2009-10-16 | Senior Vice President |
Cavan M. Redmond Latest Holdings Summary
Cavan M. Redmond currently owns a total of 1 stock. Cavan M. Redmond owns 5,543 shares of OncoCyte Corp (OCX) as of March 16, 2022, with a value of $16,463.
Latest Holdings of Cavan M. Redmond
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OCX | OncoCyte Corp | 2022-03-16 | 5,543 | 2.97 | 16,463 |
Holding Weightings of Cavan M. Redmond
Cavan M. Redmond Form 4 Trading Tracker
According to the SEC Form 4 filings, Cavan M. Redmond has made a total of 1 transactions in OncoCyte Corp (OCX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in OncoCyte Corp is the acquisition of 2,000 shares on March 16, 2022, which cost Cavan M. Redmond around $47,600.
Insider Trading History of Cavan M. Redmond
- 1
Cavan M. Redmond Trading Performance
GuruFocus tracks the stock performance after each of Cavan M. Redmond's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cavan M. Redmond is -14.17%. GuruFocus also compares Cavan M. Redmond's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cavan M. Redmond within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Cavan M. Redmond's insider trading performs compared to the benchmark.
Performance of Cavan M. Redmond
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5 | | | | | |
| Relative Return to S&P 500(%) | 4.2 | | | | | |
Cavan M. Redmond Ownership Network
Cavan M. Redmond Owned Company Details
What does OncoCyte Corp do?
Who are the key executives at OncoCyte Corp?
Cavan M. Redmond is the director of OncoCyte Corp. Other key executives at OncoCyte Corp include 10 percent owner Broadwood Partners Lp , Interim CEO Josh Riggs , and other: Former Director John Peter Gutfreund .
OncoCyte Corp (OCX) Insider Trades Summary
Over the past 18 months, Cavan M. Redmond made no insider transaction in OncoCyte Corp (OCX). Other recent insider transactions involving OncoCyte Corp (OCX) include a net purchase of 29,247,638 shares made by Broadwood Partners Lp , a net purchase of 663,000 shares made by Pura Vida Investments, Llc , and a net purchase of 33,898 shares made by Andrew Arno .
In summary, during the past 3 months, insiders sold 0 shares of OncoCyte Corp (OCX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of OncoCyte Corp (OCX) were sold and 3,833,320 shares were bought by its insiders, resulting in a net purchase of 3,833,320 shares.
OncoCyte Corp (OCX)'s detailed insider trading history can be found in Insider Trading Tracker table.
OncoCyte Corp Insider Transactions
Cavan M. Redmond Mailing Address
Above is the net worth, insider trading, and ownership report for Cavan M. Redmond. You might contact Cavan M. Redmond via mailing address: 5 Giralda Farms, Madison Nj 07940.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
